SynthesisFrontiers in oncology2026

NALIRIFOX versus FOLFIRINOX: reconstructed individual patient data meta-analysis of efficacy and safety in first-line treatment of unresectable or metastatic pancreatic ductal adenocarcinoma.

Abdullah Esmail et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.